New blood test could replace scans for HPV cancer patients

NCT ID NCT06640283

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a simple blood test that looks for tumor DNA from HPV-related cervical and anal cancers after radiation treatment. The goal is to see if this test can replace expensive imaging scans and help doctors find early signs of cancer returning. If the test is positive, patients may get immunotherapy early to try to improve outcomes. The trial involves 150 adults in Brazil and aims to make the test affordable for public healthcare.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV-RELATED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anal canal cancer anal squamous cell carcinoma cervical cancer cervical carcinoma cloacogenic carcinoma human papillomavirus-related squamous cell carcinoma Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto do Câncer do Estado de São Paulo - ICESP

    RECRUITING

    São Paulo, 01246-000, Brazil

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••